Table 2.
BCA parameters.
| Variable | All patients (n = 754) |
|---|---|
| SM, ml | 5,635.1 (3,387.1–7,412.5) |
| TAT, ml | 10,795.1 (7,537.9–15,337.7) |
| IMAT, ml | 903.3 (582.7–1,454.3) |
| SAT, ml | 5,575.9 (3,692.1–8,259.7) |
| VAT, ml | 3,911.8 (2,439.1–5,573.4) |
| SM normalized∗ | 71.1 (60.1–83.4) |
| TAT normalized∗ | 153.0 (110.2–195.9) |
| IMAT normalized∗ | 12.6 (9.0–17.3) |
| SAT normalized∗ | 76.7 (55.6–102.8) |
| VAT normalized∗ | 54.2 (36.3–76.2) |
| SM/Bone | 2.5 (2.2–2.8) |
| TAT/Bone | 5.4 (3.8–7.1) |
| IMAT/Bone | 0.5 (0.3–0.6) |
| SAT/Bone | 2.7 (2.0–3.7) |
| VAT/Bone | 1.9 (1.2–2.7) |
| Sarcopenia marker | 2.5 (2.1–2.8) |
| SM/height2∗∗ | 23.6 (20.1–27.9) |
| TAT/height2∗∗ | 52.2 (38.1–66.9) |
| IMAT/height2∗∗ | 4.2 (3.1–5.9) |
| SAT/height2∗∗ | 26.2 (18.8–35.2) |
| VAT/height2∗∗ | 19.2 (12.8–26.6) |
All data are presented as median (IQR).
BCA, body composition assessment; BCLC, Barcelona Clinic Liver Cancer; IMAT, intermuscular adipose tissue; SAT, subcutaneous adipose tissue; SM, skeletal muscle volume; TAT, total adipose tissue; VAT, visceral adipose tissue.
∗
Volumes normalized to the slice number of the abdominal cavity.
∗∗
Height only available in n = 522 patients.